3D Printed Drugs Market is expected to reach US$ 57.03 Mn by 2027

Page 1

3D

Printed Drugs Market 3D Printed Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Dosage Forms (Tablets, Capsules, Multi Drug Implant, Nanoparticles, Solutions, Others); Technology (Inkjet Printing, Direct Write, Zip Dose, Thermal Inkjet Printing, Fused Deposition Modeling, Powder Bed Printing, Stereolithography (SLA), Semi Solid Extrusion (SSE)), and Geography

Current and future Market Scenario

According to The Insight Partners market research study titled “3D Printed Drugs Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Dosage Forms and Technology,” the global 3D printed drugs market is expected to reach US$ 57.03 Mn in 2027 from US$ 28.52 Mn in 2019. The market is estimated to grow at a CAGR of 9.1% from 2020 to 2027. The report provides trends prevailing in the 3D printed drug ecosystem, and the driving factors and restraining factors pertaining to the market.

3D Printed Drugs Market
Market Segments 3D Printed Drugs Market By Dosage Forms Tablets Capsules Multi Drug Implants Nanoparticles Solutions Others By Technology Inkjet Printing Direct Write Zip Dose Thermal Inkjet Printing Fused Deposition Modeling Powder Bed Printing By Geography North America Europe Asia Pacific (APAC) Middle East and Africa (MEA) South and Central America (SCAM)
Leading Players 3D Printed Drugs Market Company Profiles in 3D Printed Drugs Market are: APRECIA PHARMACEUTICALS, LLC FabRx LTD Cycle Pharmaceuticals GLAXOSMITHKLINE PLC. ASTRAZENECA Tvasta Merck KGGA Terumo Corporation.
Thank You! 3D Printed Drugs Market Access Full Research Report at: https://www.theinsightpartners.com/reports/3d-printed-drugs-market Thank You!

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.